Drug Costs

Impacto econômico do custo de colírios no tratamento do glaucoma

Brazil / Humans / Glaucoma / Generic Drugs / Optometry and Ophthalmology / Drug Costs / Ophthalmic Solutions / Arquivos brasileiros / Drug Costs / Ophthalmic Solutions / Arquivos brasileiros

Gastos do Ministério da Saúde do Brasil com Medicamentos de Alto Custo: Uma Análise Centrada no Paciente

Brazil / Health Services Research / Health Policy / Applied Economics / Humans / Program Development / Female / Male / Health Care Rationing / Middle Aged / Health Expenditures / Public health systems and services research / Time Factors / Economic Models / Drug Costs / Drug Utilization / Ministry of Health / Government Regulation / Program Development / Female / Male / Health Care Rationing / Middle Aged / Health Expenditures / Public health systems and services research / Time Factors / Economic Models / Drug Costs / Drug Utilization / Ministry of Health / Government Regulation

Análise de Custo-Efetividade da Sinvastatina versus Atorvastatina na Prevenção Secundária de Eventos Cardiovasculares no Sistema Único de Saúde Brasileiro

Brazil / Treatment Outcome / Risk assessment / Cardiovascular disease / Applied Economics / Humans / Female / Male / Value / Cost effectiveness / Risk factors / Middle Aged / Public health systems and services research / Time Factors / Economic Models / Cost Benefit Analysis / Drug Costs / Economic evaluation / Cardiovascular Diseases / Cost Savings / Biological markers / Risk Factors / Risk Assessment / Healthcare system / SECONDARY PREVENTION / Simvastatin / Humans / Female / Male / Value / Cost effectiveness / Risk factors / Middle Aged / Public health systems and services research / Time Factors / Economic Models / Cost Benefit Analysis / Drug Costs / Economic evaluation / Cardiovascular Diseases / Cost Savings / Biological markers / Risk Factors / Risk Assessment / Healthcare system / SECONDARY PREVENTION / Simvastatin

Disponibilidade No Setor Público E Preços No Setor Privado: Um Perfil De Medicamentos Genéricos Em Diferentes Regiões Do Brasil

Brazil / Access to essential medicines / Public Health / Public sector / Humans / Price Competition / Generic Drugs / Private Sector / Drug Costs / Drug Prices / Price Competition / Generic Drugs / Private Sector / Drug Costs / Drug Prices

Disponibilidade no setor público e preços no setor privado: um perfi l de medicamentos genéricos em diferentes regiões do Brasil Availability of generic drugs in the public sector and prices in the private sector in different regions of Brazil

Brazil / Access to essential medicines / Public Health / Public sector / Humans / Price Competition / Generic Drugs / Private Sector / Drug Costs / Drug Prices / Price Competition / Generic Drugs / Private Sector / Drug Costs / Drug Prices

Disponibilidade no setor público e preços no setor privado: um perfi l de medicamentos genéricos em diferentes regiões do Brasil Availability of generic drugs in the public sector and prices in the private sector in different regions of Brazil

Brazil / Access to essential medicines / Public Health / Public sector / Humans / Price Competition / Generic Drugs / Private Sector / Drug Costs / Drug Prices / Price Competition / Generic Drugs / Private Sector / Drug Costs / Drug Prices

Análise de Custo-Efetividade da Sinvastatina versus Atorvastatina na Prevenção Secundária de Eventos Cardiovasculares no Sistema Único de Saúde Brasileiro

Brazil / Treatment Outcome / Risk assessment / Cardiovascular disease / Applied Economics / Humans / Female / Male / Value / Cost effectiveness / Risk factors / Middle Aged / Public health systems and services research / Time Factors / Economic Models / Cost Benefit Analysis / Drug Costs / Economic evaluation / Cardiovascular Diseases / Cost Savings / Biological markers / Risk Factors / Risk Assessment / Healthcare system / SECONDARY PREVENTION / Simvastatin / Humans / Female / Male / Value / Cost effectiveness / Risk factors / Middle Aged / Public health systems and services research / Time Factors / Economic Models / Cost Benefit Analysis / Drug Costs / Economic evaluation / Cardiovascular Diseases / Cost Savings / Biological markers / Risk Factors / Risk Assessment / Healthcare system / SECONDARY PREVENTION / Simvastatin

Despite steep costs, payments for new cancer drugs make economic sense

Humans / Neoplasms / Drug Costs / Antineoplastic Agents

Gastos da Secretaria Municipal de Saúde do Rio de Janeiro, Brasil, com medicamentos: uma análise do período 2002-2011

Brazil / Humans / Health Expenditures / Drug Costs / Urban Population / Drug Utilization

Presenting Germany’s drug pricing rule as a cost-per-QALY rule

Quality of Mental Health Care / Germany / Humans / Prescription drugs / Quality adjusted life years / Public health systems and services research / Cost Benefit Analysis / Drug Costs / Drug Industry / Public health systems and services research / Cost Benefit Analysis / Drug Costs / Drug Industry

Copyright © 2017 DADOSPDF Inc.